Similar to the latter study, which also found evidence indicative of increased CRH expression, another study in adult rats of both sexes exposed to MS showed reduced Crh promoter CpG1 and CpG2 methylation, but in the paraventricular nucleus (PVN) of the hypothalamus [119]. Here, CRH is linked to myeloid sarcoma.